CellaVision in short
CellaVision is an innovative, global medical technology company that develops and sells best-in-class systems for the routine analysis of blood and other body fluids. These analyses often provide critical results used in the diagnosis of a variety of illnesses such as infection and cancer.
The company has leading-edge expertise in digital image analysis, artificial intelligence and automated microscopy. CellaVision has its head office in Lund, Sweden, and subsidiaries in the US, Canada and Japan. The company share is listed on Nasdaq OMX Stockholm, Small Cap.
CellaVision's target is to increase sales by an average of at least 15 % per year over an economic cycle with an operating margin of more than 15 %.